1. Home
  2. RSF vs CPHI Comparison

RSF vs CPHI Comparison

Compare RSF & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Capital and Income Fund

RSF

RiverNorth Capital and Income Fund

HOLD

Current Price

$14.52

Market Cap

58.6M

Sector

Finance

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.08

Market Cap

61.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSF
CPHI
Founded
2016
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.6M
61.6M
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
RSF
CPHI
Price
$14.52
$1.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
5.2M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
10.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.23
$0.38
52 Week High
$15.07
$19.19

Technical Indicators

Market Signals
Indicator
RSF
CPHI
Relative Strength Index (RSI) 45.51 48.09
Support Level $14.51 $0.54
Resistance Level $14.70 $1.43
Average True Range (ATR) 0.07 0.10
MACD -0.00 -0.04
Stochastic Oscillator 24.05 10.86

Price Performance

Historical Comparison
RSF
CPHI

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: